Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertolini

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Drug Discovery Today|August 31, 2011
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancerFrancesco Bertolini, Paola Marighetti, Ines Martin-Padura, et al.
Biotechniques|July 10, 2010
Miniaturized FISH for screening of onco-hematological malignanciesAndrea Zanardi, Dario Bandiera, Francesco Bertolini, et al.
International Journal of Cancer|December 4, 2010
Circulating perivascular progenitors: a target of PDGFR inhibitionPatrizia Mancuso, Ines Martin-Padura, Angelica Calleri, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2019
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedsideAmal Kamal Abdel-Aziz, Mona Kamal Saadeldin, Paolo D'Amico, et al.
Cancer Research|December 3, 2020
Cyclophosphamide and Vinorelbine Activate Stem-Like CD8<sup>+</sup> T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast CancerPaolo Falvo, Stefania Orecchioni, Roman Hillje, et al.
Ecancermedicalscience|December 5, 2015
Biomarkers of cancer angioprevention for clinical studiesAdriana Albini, Francesco Bertolini, Barbara Bassani, et al.
International Journal of Cancer|August 9, 2008
Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strainsAlice Agliano, Ines Martin-Padura, Patrizia Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitorsManuela Capillo, Patrizia Mancuso, Alberto Gobbi, et al.
Immunologic Research|August 26, 2025
Sex-related differences in cell-free DNA and neutrophil extracellular traps in patients with hematologic malignanciesGaia Gnecco, Alessandro Davini, Arianna Valeriano, et al.
Cancer Research|May 31, 2002
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphomaFrancesco Bertolini, Chiara Dell'Agnola, Patrizia Mancuso, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Drug Discovery Today|August 31, 2011
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancerFrancesco Bertolini, Paola Marighetti, Ines Martin-Padura, et al.
Biotechniques|July 10, 2010
Miniaturized FISH for screening of onco-hematological malignanciesAndrea Zanardi, Dario Bandiera, Francesco Bertolini, et al.
International Journal of Cancer|December 4, 2010
Circulating perivascular progenitors: a target of PDGFR inhibitionPatrizia Mancuso, Ines Martin-Padura, Angelica Calleri, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2019
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedsideAmal Kamal Abdel-Aziz, Mona Kamal Saadeldin, Paolo D'Amico, et al.
Cancer Research|December 3, 2020
Cyclophosphamide and Vinorelbine Activate Stem-Like CD8<sup>+</sup> T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast CancerPaolo Falvo, Stefania Orecchioni, Roman Hillje, et al.
Ecancermedicalscience|December 5, 2015
Biomarkers of cancer angioprevention for clinical studiesAdriana Albini, Francesco Bertolini, Barbara Bassani, et al.
International Journal of Cancer|August 9, 2008
Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strainsAlice Agliano, Ines Martin-Padura, Patrizia Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitorsManuela Capillo, Patrizia Mancuso, Alberto Gobbi, et al.
Immunologic Research|August 26, 2025
Sex-related differences in cell-free DNA and neutrophil extracellular traps in patients with hematologic malignanciesGaia Gnecco, Alessandro Davini, Arianna Valeriano, et al.
Cancer Research|May 31, 2002
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphomaFrancesco Bertolini, Chiara Dell'Agnola, Patrizia Mancuso, et al.
Pageof 17